Share
 
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
14:30
WEAB0201
Daily is better than thrice-weekly anti-tuberculosis therapy in HIV patients with culture confirmed pulmonary TB: a randomised controlled clinical trial from south India
Narendran Gopalan, National Institute for Research in Tuberculosis, India
Abstract
Slides

14:45
WEAB0202
Intensified tuberculosis case-finding among people living with HIV: diagnostic yield of Xpert MTB/RIF, urine lipoarabinomannan and liquid culture
Fred Collins Semitala, Makerere University College of Health Sciences, Uganda
Abstract
Slides

15:00
WEAB0203
Cytomegalovirus viraemia and 12-week mortality among hospitalised adults with HIV-associated tuberculosis in Khayelitsha Hospital, South Africa: a prospective cohort study
Amy Ward, University of Cape Town, South Africa
Abstract
Slides

15:15
WEAB0204
Yield of community health worker-driven intensified case finding for tuberculosis among HIV-positive patients in rural Malawi
Katie Simon, Baylor College of Medicine Children’s Foundation Malawi, Malawi
Abstract
Slides

15:30
WEAB0205LB
High-dose rifampicin tuberculosis treatment regimen to reduce 12-month mortality of TB/HIV co-infected patients: the RAFA trial results
Corinne Merle, London School of Hygiene and Tropical Medicine, Switzerland
Abstract
Slides

15:45
WEAB0206
Moderated discussion